Rangeley Capital, LLC Liquidia Corp Transaction History
Rangeley Capital, LLC
- $111 Billion
- Q4 2024
A detailed history of Rangeley Capital, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Rangeley Capital, LLC holds 191,000 shares of LQDA stock, worth $3.08 Million. This represents 2.02% of its overall portfolio holdings.
Number of Shares
191,000Holding current value
$3.08 Million% of portfolio
2.02%Shares
1 transactions
Others Institutions Holding LQDA
# of Institutions
188Shares Held
44.2MCall Options Held
1.48MPut Options Held
1.14M-
Black Rock Inc. New York, NY4.24MShares$68.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$57.4 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.29MShares$53.1 Million0.21% of portfolio
-
Findell Capital Management LLC New York, NY3.08MShares$49.7 Million14.82% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.27MShares$36.6 Million1.69% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.04B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...